SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '86X'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JHO_A_NIOA991_1 (NICOTINATEMONONUCLEOTIDE:5,6-DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 5 / 9 | THR A 439GLY A 490SER A 588GLU A 441GLY A 590 | 86X A1004 (-3.6A)None86X A1004 (-3.6A)86X A1004 (-3.0A)86X A1004 ( 4.2A) | 0.99A | 1jhoA-5xiiA:undetectable | 1jhoA-5xiiA:11.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JHR_A_NIOA991_1 (NICOTINATEMONONUCLEOTIDE:5,6-DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 5 / 9 | THR A 439GLY A 490SER A 588GLU A 441GLY A 590 | 86X A1004 (-3.6A)None86X A1004 (-3.6A)86X A1004 (-3.0A)86X A1004 ( 4.2A) | 1.01A | 1jhrA-5xiiA:undetectable | 1jhrA-5xiiA:11.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JHY_A_NIOA991_1 (NICOTINATEMONONUCLEOTIDE:5,6-DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 5 / 9 | THR A 439GLY A 490SER A 588GLU A 441GLY A 590 | 86X A1004 (-3.6A)None86X A1004 (-3.6A)86X A1004 (-3.0A)86X A1004 ( 4.2A) | 1.01A | 1jhyA-5xiiA:undetectable | 1jhyA-5xiiA:11.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L4N_A_NIOA991_1 (NICOTINATE-NUCLEOTIDE--DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 5 / 9 | THR A 439GLY A 490SER A 588GLU A 441GLY A 590 | 86X A1004 (-3.6A)None86X A1004 (-3.6A)86X A1004 (-3.0A)86X A1004 ( 4.2A) | 1.02A | 1l4nA-5xiiA:undetectable | 1l4nA-5xiiA:11.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L5K_A_NIOA991_1 (NICOTINATE-NUCLEOTIDE--DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 5 / 9 | THR A 439GLY A 490SER A 588GLU A 441GLY A 590 | 86X A1004 (-3.6A)None86X A1004 (-3.6A)86X A1004 (-3.0A)86X A1004 ( 4.2A) | 1.00A | 1l5kA-5xiiA:undetectable | 1l5kA-5xiiA:11.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L5L_A_NIOA991_1 (NICOTINATE-NUCLEOTIDE--DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 5 / 9 | THR A 439GLY A 490SER A 588GLU A 441GLY A 590 | 86X A1004 (-3.6A)None86X A1004 (-3.6A)86X A1004 (-3.0A)86X A1004 ( 4.2A) | 1.00A | 1l5lA-5xiiA:undetectable | 1l5lA-5xiiA:11.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L5M_A_NIOA991_1 (NICOTINATE-NUCLEOTIDE--DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 5 / 9 | THR A 439GLY A 490SER A 588GLU A 441GLY A 590 | 86X A1004 (-3.6A)None86X A1004 (-3.6A)86X A1004 (-3.0A)86X A1004 ( 4.2A) | 1.00A | 1l5mA-5xiiA:undetectable | 1l5mA-5xiiA:11.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HVC_A_HFGA1602_0 (BIFUNCTIONALGLUTAMATE/PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 6 / 12 | GLU A 472GLU A 489HIS A 491THR A 558SER A 588GLY A 590 | ANP A1001 (-3.4A)None86X A1004 ( 4.8A)86X A1004 (-3.9A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 0.96A | 4hvcA-5xiiA:51.5 | 4hvcA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HVC_A_HFGA1602_0 (BIFUNCTIONALGLUTAMATE/PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 11 / 12 | PHE A 415GLU A 418VAL A 419PRO A 438TRP A 487GLU A 489HIS A 491PHE A 534THR A 558SER A 588GLY A 590 | 86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)NoneNone86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.9A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 0.33A | 4hvcA-5xiiA:51.5 | 4hvcA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HVC_A_HFGA1602_1 (BIFUNCTIONALGLUTAMATE/PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 4 / 4 | THR A 439GLU A 441ARG A 470HIS A 560 | 86X A1004 (-3.6A)86X A1004 (-3.0A)ANP A1001 ( 2.9A)86X A1004 (-3.7A) | 0.16A | 4hvcA-5xiiA:51.5 | 4hvcA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HVC_B_HFGB1602_0 (BIFUNCTIONALGLUTAMATE/PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 6 / 12 | GLU A 472GLU A 489HIS A 491THR A 558SER A 588GLY A 590 | ANP A1001 (-3.4A)None86X A1004 ( 4.8A)86X A1004 (-3.9A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 1.01A | 4hvcB-5xiiA:51.8 | 4hvcB-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HVC_B_HFGB1602_0 (BIFUNCTIONALGLUTAMATE/PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 12 / 12 | LEU A 405PHE A 415GLU A 418VAL A 419PRO A 438TRP A 487GLU A 489HIS A 491PHE A 534THR A 558SER A 588GLY A 590 | None86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)NoneNone86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.9A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 0.33A | 4hvcB-5xiiA:51.8 | 4hvcB-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HVC_B_HFGB1602_1 (BIFUNCTIONALGLUTAMATE/PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 4 / 5 | THR A 439GLU A 441ARG A 470HIS A 560 | 86X A1004 (-3.6A)86X A1004 (-3.0A)ANP A1001 ( 2.9A)86X A1004 (-3.7A) | 0.17A | 4hvcB-5xiiA:51.8 | 4hvcB-5xiiA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K87_A_ADNA602_1 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 6 / 8 | ARG A 470PHE A 485GLN A 555THR A 558THR A 592ARG A 594 | ANP A1001 ( 2.9A)ANP A1001 (-3.4A)ANP A1001 (-3.6A)86X A1004 (-3.9A)ANP A1001 (-2.7A)ANP A1001 (-3.7A) | 0.55A | 4k87A-5xiiA:50.1 | 4k87A-5xiiA:58.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K88_A_HFGA602_0 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 8 / 12 | GLU A 472THR A 439GLU A 441ARG A 470GLU A 489PHE A 534HIS A 560SER A 588 | ANP A1001 (-3.4A)86X A1004 (-3.6A)86X A1004 (-3.0A)ANP A1001 ( 2.9A)None86X A1004 (-3.6A)86X A1004 (-3.7A)86X A1004 (-3.6A) | 1.45A | 4k88A-5xiiA:49.9 | 4k88A-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K88_A_HFGA602_0 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 12 / 12 | PHE A 415GLU A 418VAL A 419PRO A 438THR A 439GLU A 441ARG A 470TRP A 487GLU A 489PHE A 534HIS A 560SER A 588 | 86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)86X A1004 (-3.6A)86X A1004 (-3.0A)ANP A1001 ( 2.9A)NoneNone86X A1004 (-3.6A)86X A1004 (-3.7A)86X A1004 (-3.6A) | 0.63A | 4k88A-5xiiA:49.9 | 4k88A-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KQI_A_NIOA403_1 (NICOTINATE-NUCLEOTIDE--DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 5 / 9 | THR A 439GLY A 490SER A 588GLU A 441GLY A 590 | 86X A1004 (-3.6A)None86X A1004 (-3.6A)86X A1004 (-3.0A)86X A1004 ( 4.2A) | 1.05A | 4kqiA-5xiiA:undetectable | 4kqiA-5xiiA:11.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OLF_A_HFGA802_0 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 7 / 12 | GLU A 472TRP A 487GLU A 489HIS A 491THR A 558SER A 588TRP A 589 | ANP A1001 (-3.4A)NoneNone86X A1004 ( 4.8A)86X A1004 (-3.9A)86X A1004 (-3.6A)None | 1.17A | 4olfA-5xiiA:52.6 | 4olfA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OLF_A_HFGA802_0 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 12 / 12 | PHE A 415GLU A 418VAL A 419PRO A 438TRP A 487GLU A 489HIS A 491PHE A 534THR A 558SER A 588TRP A 589GLY A 590 | 86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)NoneNone86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.9A)86X A1004 (-3.6A)None86X A1004 ( 4.2A) | 0.33A | 4olfA-5xiiA:52.6 | 4olfA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OLF_A_HFGA802_0 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 5 / 12 | PHE A 415HIS A 491PHE A 534THR A 540SER A 588 | 86X A1004 (-3.6A)86X A1004 ( 4.8A)86X A1004 (-3.6A)None86X A1004 (-3.6A) | 1.36A | 4olfA-5xiiA:52.6 | 4olfA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OLF_A_HFGA802_1 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 4 / 4 | THR A 439GLU A 441ARG A 470HIS A 560 | 86X A1004 (-3.6A)86X A1004 (-3.0A)ANP A1001 ( 2.9A)86X A1004 (-3.7A) | 0.27A | 4olfA-5xiiA:52.6 | 4olfA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Q15_A_HFGA803_0 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 7 / 12 | GLU A 472THR A 439ARG A 470TRP A 487HIS A 491SER A 588GLY A 590 | ANP A1001 (-3.4A)86X A1004 (-3.6A)ANP A1001 ( 2.9A)None86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 1.33A | 4q15A-5xiiA:50.4 | 4q15A-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Q15_A_HFGA803_0 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 12 / 12 | LEU A 405PHE A 415GLU A 418VAL A 419PRO A 438THR A 439ARG A 470TRP A 487HIS A 491PHE A 534SER A 588GLY A 590 | None86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)86X A1004 (-3.6A)ANP A1001 ( 2.9A)None86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 0.27A | 4q15A-5xiiA:50.4 | 4q15A-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Q15_A_HFGA803_1 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 3 / 3 | GLU A 441THR A 558HIS A 560 | 86X A1004 (-3.0A)86X A1004 (-3.9A)86X A1004 (-3.7A) | 0.36A | 4q15A-5xiiA:50.4 | 4q15A-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Q15_B_HFGB803_0 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 7 / 12 | GLU A 472THR A 439ARG A 470TRP A 487GLU A 489SER A 588GLY A 590 | ANP A1001 (-3.4A)86X A1004 (-3.6A)ANP A1001 ( 2.9A)NoneNone86X A1004 (-3.6A)86X A1004 ( 4.2A) | 1.31A | 4q15B-5xiiA:51.3 | 4q15B-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Q15_B_HFGB803_0 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 12 / 12 | LEU A 405PHE A 415GLU A 418VAL A 419PRO A 438THR A 439ARG A 470TRP A 487GLU A 489PHE A 534SER A 588GLY A 590 | None86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)86X A1004 (-3.6A)ANP A1001 ( 2.9A)NoneNone86X A1004 (-3.6A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 0.24A | 4q15B-5xiiA:51.3 | 4q15B-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Q15_B_HFGB803_1 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 3 / 3 | GLU A 441THR A 558HIS A 560 | 86X A1004 (-3.0A)86X A1004 (-3.9A)86X A1004 (-3.7A) | 0.37A | 4q15B-5xiiA:51.3 | 4q15B-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YDQ_A_HFGA802_0 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 5 / 12 | GLU A 472ARG A 470GLU A 489HIS A 491SER A 588 | ANP A1001 (-3.4A)ANP A1001 ( 2.9A)None86X A1004 ( 4.8A)86X A1004 (-3.6A) | 1.38A | 4ydqA-5xiiA:53.3 | 4ydqA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YDQ_A_HFGA802_0 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 11 / 12 | LEU A 405PHE A 415GLU A 418VAL A 419PRO A 438ARG A 470GLU A 489HIS A 491PHE A 534SER A 588GLY A 590 | None86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)ANP A1001 ( 2.9A)None86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 0.29A | 4ydqA-5xiiA:53.3 | 4ydqA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YDQ_A_HFGA802_0 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 10 / 12 | LEU A 405PHE A 415GLU A 418VAL A 419PRO A 438ARG A 470TRP A 487PHE A 534SER A 588GLY A 590 | None86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)ANP A1001 ( 2.9A)None86X A1004 (-3.6A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 0.62A | 4ydqA-5xiiA:53.3 | 4ydqA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YDQ_A_HFGA802_1 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 4 / 4 | THR A 439GLU A 441THR A 558HIS A 560 | 86X A1004 (-3.6A)86X A1004 (-3.0A)86X A1004 (-3.9A)86X A1004 (-3.7A) | 0.31A | 4ydqA-5xiiA:53.3 | 4ydqA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YDQ_B_HFGB802_0 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 6 / 12 | GLU A 472THR A 439ARG A 470GLU A 489HIS A 491SER A 588 | ANP A1001 (-3.4A)86X A1004 (-3.6A)ANP A1001 ( 2.9A)None86X A1004 ( 4.8A)86X A1004 (-3.6A) | 1.41A | 4ydqB-5xiiA:52.8 | 4ydqB-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YDQ_B_HFGB802_0 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 11 / 12 | PHE A 415GLU A 418VAL A 419PRO A 438THR A 439ARG A 470GLU A 489HIS A 491PHE A 534SER A 588GLY A 590 | 86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)86X A1004 (-3.6A)ANP A1001 ( 2.9A)None86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 0.46A | 4ydqB-5xiiA:52.8 | 4ydqB-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YDQ_B_HFGB802_0 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 9 / 12 | VAL A 419PRO A 438THR A 439ARG A 470TRP A 487HIS A 491PHE A 534SER A 588GLY A 590 | 86X A1004 (-4.2A)86X A1004 (-4.3A)86X A1004 (-3.6A)ANP A1001 ( 2.9A)None86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 0.66A | 4ydqB-5xiiA:52.8 | 4ydqB-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YDQ_B_HFGB802_1 (PROLINE--TRNA LIGASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 3 / 3 | GLU A 441THR A 558HIS A 560 | 86X A1004 (-3.0A)86X A1004 (-3.9A)86X A1004 (-3.7A) | 0.35A | 4ydqB-5xiiA:52.8 | 4ydqB-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5F9Z_A_HFGA702_0 (AMINOACYL-TRNASYNTHETASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 6 / 12 | GLU A 472ARG A 470TRP A 487GLU A 489SER A 588GLY A 590 | ANP A1001 (-3.4A)ANP A1001 ( 2.9A)NoneNone86X A1004 (-3.6A)86X A1004 ( 4.2A) | 1.29A | 5f9zA-5xiiA:51.8 | 5f9zA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5F9Z_A_HFGA702_0 (AMINOACYL-TRNASYNTHETASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 10 / 12 | LEU A 405GLU A 418VAL A 419PRO A 438ARG A 470TRP A 487GLU A 489PHE A 534SER A 588GLY A 590 | None MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)ANP A1001 ( 2.9A)NoneNone86X A1004 (-3.6A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 0.26A | 5f9zA-5xiiA:51.8 | 5f9zA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5F9Z_A_HFGA702_1 (AMINOACYL-TRNASYNTHETASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 4 / 4 | THR A 439GLU A 441THR A 558HIS A 560 | 86X A1004 (-3.6A)86X A1004 (-3.0A)86X A1004 (-3.9A)86X A1004 (-3.7A) | 0.24A | 5f9zA-5xiiA:51.8 | 5f9zA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5F9Z_B_HFGB703_0 (AMINOACYL-TRNASYNTHETASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 6 / 12 | GLU A 472ARG A 470TRP A 487GLU A 489SER A 588GLY A 590 | ANP A1001 (-3.4A)ANP A1001 ( 2.9A)NoneNone86X A1004 (-3.6A)86X A1004 ( 4.2A) | 1.29A | 5f9zB-5xiiA:51.9 | 5f9zB-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5F9Z_B_HFGB703_0 (AMINOACYL-TRNASYNTHETASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 10 / 12 | LEU A 405GLU A 418VAL A 419PRO A 438ARG A 470TRP A 487GLU A 489PHE A 534SER A 588GLY A 590 | None MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)ANP A1001 ( 2.9A)NoneNone86X A1004 (-3.6A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 0.28A | 5f9zB-5xiiA:51.9 | 5f9zB-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5F9Z_B_HFGB703_0 (AMINOACYL-TRNASYNTHETASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 6 / 12 | LEU A 405SER A 416VAL A 419GLU A 489PHE A 534SER A 588 | NoneNone86X A1004 (-4.2A)None86X A1004 (-3.6A)86X A1004 (-3.6A) | 1.20A | 5f9zB-5xiiA:51.9 | 5f9zB-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5F9Z_B_HFGB703_1 (AMINOACYL-TRNASYNTHETASE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 4 / 4 | THR A 439GLU A 441THR A 558HIS A 560 | 86X A1004 (-3.6A)86X A1004 (-3.0A)86X A1004 (-3.9A)86X A1004 (-3.7A) | 0.24A | 5f9zB-5xiiA:51.9 | 5f9zB-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIO_A_HFGA801_0 (PROLINE-TRNASYNTHETASE CLASS IIAARS (YBAK RNABINDING DOMAIN PLUSTRNA SYNTHETASE)) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 9 / 12 | PHE A 415GLU A 418VAL A 419PRO A 438ARG A 470PHE A 534THR A 558SER A 588GLY A 590 | 86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)ANP A1001 ( 2.9A)86X A1004 (-3.6A)86X A1004 (-3.9A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 0.65A | 5xioA-5xiiA:51.7 | 5xioA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIO_A_HFGA801_0 (PROLINE-TRNASYNTHETASE CLASS IIAARS (YBAK RNABINDING DOMAIN PLUSTRNA SYNTHETASE)) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 11 / 12 | PHE A 415VAL A 419PRO A 438ARG A 470TRP A 487GLU A 489HIS A 491PHE A 534THR A 558SER A 588GLY A 590 | 86X A1004 (-3.6A)86X A1004 (-4.2A)86X A1004 (-4.3A)ANP A1001 ( 2.9A)NoneNone86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.9A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 0.40A | 5xioA-5xiiA:51.7 | 5xioA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIO_A_HFGA801_1 (PROLINE-TRNASYNTHETASE CLASS IIAARS (YBAK RNABINDING DOMAIN PLUSTRNA SYNTHETASE)) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 3 / 3 | THR A 439GLU A 441HIS A 560 | 86X A1004 (-3.6A)86X A1004 (-3.0A)86X A1004 (-3.7A) | 0.07A | 5xioA-5xiiA:51.7 | 5xioA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIO_B_HFGB802_0 (PROLINE-TRNASYNTHETASE CLASS IIAARS (YBAK RNABINDING DOMAIN PLUSTRNA SYNTHETASE)) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 8 / 12 | GLU A 472THR A 439ARG A 470GLU A 489HIS A 491PHE A 534THR A 558HIS A 560 | ANP A1001 (-3.4A)86X A1004 (-3.6A)ANP A1001 ( 2.9A)None86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.9A)86X A1004 (-3.7A) | 1.25A | 5xioB-5xiiA:51.8 | 5xioB-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIO_B_HFGB802_0 (PROLINE-TRNASYNTHETASE CLASS IIAARS (YBAK RNABINDING DOMAIN PLUSTRNA SYNTHETASE)) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 12 / 12 | PHE A 415GLU A 418VAL A 419PRO A 438THR A 439ARG A 470TRP A 487GLU A 489HIS A 491PHE A 534THR A 558HIS A 560 | 86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)86X A1004 (-3.6A)ANP A1001 ( 2.9A)NoneNone86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.9A)86X A1004 (-3.7A) | 0.47A | 5xioB-5xiiA:51.8 | 5xioB-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIP_A_HFGA1003_0 (PROLYL-TRNASYNTHETASE, PUTATIVE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 7 / 12 | GLU A 472THR A 439ARG A 470HIS A 491THR A 558SER A 588GLY A 590 | ANP A1001 (-3.4A)86X A1004 (-3.6A)ANP A1001 ( 2.9A)86X A1004 ( 4.8A)86X A1004 (-3.9A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 1.38A | 5xipA-5xiiA:53.0 | 5xipA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIP_A_HFGA1003_0 (PROLYL-TRNASYNTHETASE, PUTATIVE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 12 / 12 | LEU A 405PHE A 415GLU A 418VAL A 419PRO A 438THR A 439ARG A 470HIS A 491PHE A 534THR A 558SER A 588GLY A 590 | None86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)86X A1004 (-3.6A)ANP A1001 ( 2.9A)86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.9A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 0.56A | 5xipA-5xiiA:53.0 | 5xipA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIP_A_HFGA1003_1 (PROLYL-TRNASYNTHETASE, PUTATIVE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 3 / 3 | GLU A 441TRP A 487HIS A 560 | 86X A1004 (-3.0A)None86X A1004 (-3.7A) | 0.25A | 5xipA-5xiiA:53.0 | 5xipA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIP_B_HFGB1003_0 (PROLYL-TRNASYNTHETASE, PUTATIVE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 8 / 12 | GLU A 472THR A 439ARG A 470TRP A 487HIS A 491PHE A 534THR A 558HIS A 560 | ANP A1001 (-3.4A)86X A1004 (-3.6A)ANP A1001 ( 2.9A)None86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.9A)86X A1004 (-3.7A) | 1.23A | 5xipB-5xiiA:52.7 | 5xipB-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIP_B_HFGB1003_0 (PROLYL-TRNASYNTHETASE, PUTATIVE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 12 / 12 | PHE A 415GLU A 418VAL A 419PRO A 438THR A 439GLU A 441ARG A 470TRP A 487HIS A 491PHE A 534THR A 558HIS A 560 | 86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)86X A1004 (-3.6A)86X A1004 (-3.0A)ANP A1001 ( 2.9A)None86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.9A)86X A1004 (-3.7A) | 0.52A | 5xipB-5xiiA:52.7 | 5xipB-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIP_C_HFGC1003_0 (PROLYL-TRNASYNTHETASE, PUTATIVE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 7 / 12 | GLU A 472THR A 439TRP A 487GLU A 489HIS A 491THR A 558GLY A 590 | ANP A1001 (-3.4A)86X A1004 (-3.6A)NoneNone86X A1004 ( 4.8A)86X A1004 (-3.9A)86X A1004 ( 4.2A) | 1.08A | 5xipC-5xiiA:52.5 | 5xipC-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIP_C_HFGC1003_0 (PROLYL-TRNASYNTHETASE, PUTATIVE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 7 / 12 | LEU A 405GLU A 418VAL A 419GLU A 441HIS A 491PHE A 534THR A 540 | None MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-3.0A)86X A1004 ( 4.8A)86X A1004 (-3.6A)None | 1.48A | 5xipC-5xiiA:52.5 | 5xipC-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIP_C_HFGC1003_0 (PROLYL-TRNASYNTHETASE, PUTATIVE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 12 / 12 | LEU A 405GLU A 418VAL A 419PRO A 438THR A 439GLU A 441TRP A 487GLU A 489HIS A 491PHE A 534THR A 558GLY A 590 | None MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)86X A1004 (-3.6A)86X A1004 (-3.0A)NoneNone86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.9A)86X A1004 ( 4.2A) | 0.34A | 5xipC-5xiiA:52.5 | 5xipC-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIP_C_HFGC1003_0 (PROLYL-TRNASYNTHETASE, PUTATIVE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 5 / 12 | VAL A 419PRO A 438THR A 439GLU A 489PHE A 566 | 86X A1004 (-4.2A)86X A1004 (-4.3A)86X A1004 (-3.6A)NoneNone | 1.22A | 5xipC-5xiiA:52.5 | 5xipC-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIP_D_HFGD1003_0 (PROLYL-TRNASYNTHETASE, PUTATIVE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 7 / 12 | GLU A 472THR A 439GLU A 441ARG A 470TRP A 487GLU A 489TRP A 589 | ANP A1001 (-3.4A)86X A1004 (-3.6A)86X A1004 (-3.0A)ANP A1001 ( 2.9A)NoneNoneNone | 1.37A | 5xipD-5xiiA:52.6 | 5xipD-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIP_D_HFGD1003_0 (PROLYL-TRNASYNTHETASE, PUTATIVE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 6 / 12 | LEU A 405GLU A 418VAL A 419GLU A 441PHE A 534THR A 540 | None MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-3.0A)86X A1004 (-3.6A)None | 1.48A | 5xipD-5xiiA:52.6 | 5xipD-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIP_D_HFGD1003_0 (PROLYL-TRNASYNTHETASE, PUTATIVE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 12 / 12 | LEU A 405GLU A 418VAL A 419PRO A 438THR A 439GLU A 441ARG A 470TRP A 487GLU A 489PHE A 534THR A 558TRP A 589 | None MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)86X A1004 (-3.6A)86X A1004 (-3.0A)ANP A1001 ( 2.9A)NoneNone86X A1004 (-3.6A)86X A1004 (-3.9A)None | 0.39A | 5xipD-5xiiA:52.6 | 5xipD-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIP_D_HFGD1003_0 (PROLYL-TRNASYNTHETASE, PUTATIVE) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 6 / 12 | VAL A 419PRO A 438THR A 439GLU A 489PHE A 566TRP A 589 | 86X A1004 (-4.2A)86X A1004 (-4.3A)86X A1004 (-3.6A)NoneNoneNone | 1.40A | 5xipD-5xiiA:52.6 | 5xipD-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIQ_A_HFGA1002_0 (PROLYL-TRNASYNTHETASE (PRORS)) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 8 / 12 | GLU A 472TRP A 487GLU A 489HIS A 491PHE A 534THR A 558SER A 588GLY A 590 | ANP A1001 (-3.4A)NoneNone86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.9A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 1.11A | 5xiqA-5xiiA:57.6 | 5xiqA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIQ_A_HFGA1002_0 (PROLYL-TRNASYNTHETASE (PRORS)) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 12 / 12 | LEU A 405PHE A 415GLU A 418VAL A 419PRO A 438TRP A 487GLU A 489HIS A 491PHE A 534THR A 558SER A 588GLY A 590 | None86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)NoneNone86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.9A)86X A1004 (-3.6A)86X A1004 ( 4.2A) | 0.20A | 5xiqA-5xiiA:57.6 | 5xiqA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIQ_A_HFGA1002_1 (PROLYL-TRNASYNTHETASE (PRORS)) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 4 / 4 | THR A 439GLU A 441ARG A 470HIS A 560 | 86X A1004 (-3.6A)86X A1004 (-3.0A)ANP A1001 ( 2.9A)86X A1004 (-3.7A) | 0.12A | 5xiqA-5xiiA:57.6 | 5xiqA-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIQ_B_HFGB1002_0 (PROLYL-TRNASYNTHETASE (PRORS)) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 7 / 12 | GLU A 472ARG A 470GLU A 489HIS A 491PHE A 534THR A 558SER A 588 | ANP A1001 (-3.4A)ANP A1001 ( 2.9A)None86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.9A)86X A1004 (-3.6A) | 1.28A | 5xiqB-5xiiA:55.5 | 5xiqB-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIQ_B_HFGB1002_0 (PROLYL-TRNASYNTHETASE (PRORS)) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 12 / 12 | LEU A 405PHE A 415GLU A 418VAL A 419PRO A 438ARG A 470TRP A 487GLU A 489HIS A 491PHE A 534THR A 558SER A 588 | None86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)ANP A1001 ( 2.9A)NoneNone86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.9A)86X A1004 (-3.6A) | 0.23A | 5xiqB-5xiiA:55.5 | 5xiqB-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIQ_B_HFGB1002_1 (PROLYL-TRNASYNTHETASE (PRORS)) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 3 / 3 | THR A 439GLU A 441HIS A 560 | 86X A1004 (-3.6A)86X A1004 (-3.0A)86X A1004 (-3.7A) | 0.08A | 5xiqB-5xiiA:55.5 | 5xiqB-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIQ_C_HFGC1002_0 (PROLYL-TRNASYNTHETASE (PRORS)) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 7 / 12 | GLU A 472THR A 439ARG A 470GLU A 489HIS A 491THR A 558SER A 588 | ANP A1001 (-3.4A)86X A1004 (-3.6A)ANP A1001 ( 2.9A)None86X A1004 ( 4.8A)86X A1004 (-3.9A)86X A1004 (-3.6A) | 1.34A | 5xiqC-5xiiA:55.6 | 5xiqC-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIQ_C_HFGC1002_0 (PROLYL-TRNASYNTHETASE (PRORS)) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 12 / 12 | PHE A 415GLU A 418VAL A 419PRO A 438THR A 439ARG A 470TRP A 487GLU A 489HIS A 491PHE A 534THR A 558SER A 588 | 86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)86X A1004 (-3.6A)ANP A1001 ( 2.9A)NoneNone86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.9A)86X A1004 (-3.6A) | 0.22A | 5xiqC-5xiiA:55.6 | 5xiqC-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIQ_D_HFGD1002_0 (PROLYL-TRNASYNTHETASE (PRORS)) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 7 / 12 | GLU A 472ARG A 470TRP A 487GLU A 489HIS A 491THR A 558GLY A 590 | ANP A1001 (-3.4A)ANP A1001 ( 2.9A)NoneNone86X A1004 ( 4.8A)86X A1004 (-3.9A)86X A1004 ( 4.2A) | 1.27A | 5xiqD-5xiiA:56.3 | 5xiqD-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIQ_D_HFGD1002_0 (PROLYL-TRNASYNTHETASE (PRORS)) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 12 / 12 | LEU A 405PHE A 415GLU A 418VAL A 419PRO A 438ARG A 470TRP A 487GLU A 489HIS A 491PHE A 534THR A 558GLY A 590 | None86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)ANP A1001 ( 2.9A)NoneNone86X A1004 ( 4.8A)86X A1004 (-3.6A)86X A1004 (-3.9A)86X A1004 ( 4.2A) | 0.27A | 5xiqD-5xiiA:56.3 | 5xiqD-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIQ_D_HFGD1002_0 (PROLYL-TRNASYNTHETASE (PRORS)) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 5 / 12 | LEU A 405PHE A 415GLU A 418VAL A 419THR A 540 | None86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)None | 1.16A | 5xiqD-5xiiA:56.3 | 5xiqD-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIQ_D_HFGD1002_1 (PROLYL-TRNASYNTHETASE (PRORS)) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 3 / 3 | THR A 439GLU A 441HIS A 560 | 86X A1004 (-3.6A)86X A1004 (-3.0A)86X A1004 (-3.7A) | 0.10A | 5xiqD-5xiiA:56.3 | 5xiqD-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MN8_A_HFGA603_0 (UNCHARACTERIZEDPROTEIN) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 7 / 12 | GLU A 472GLU A 489HIS A 491THR A 558SER A 588TRP A 589GLY A 590 | ANP A1001 (-3.4A)None86X A1004 ( 4.8A)86X A1004 (-3.9A)86X A1004 (-3.6A)None86X A1004 ( 4.2A) | 1.06A | 6mn8A-5xiiA:45.0 | 6mn8A-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MN8_A_HFGA603_0 (UNCHARACTERIZEDPROTEIN) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 12 / 12 | LEU A 405PHE A 415GLU A 418VAL A 419PRO A 438TRP A 487GLU A 489HIS A 491THR A 558SER A 588TRP A 589GLY A 590 | None86X A1004 (-3.6A) MG A1003 (-4.1A)86X A1004 (-4.2A)86X A1004 (-4.3A)NoneNone86X A1004 ( 4.8A)86X A1004 (-3.9A)86X A1004 (-3.6A)None86X A1004 ( 4.2A) | 0.44A | 6mn8A-5xiiA:45.0 | 6mn8A-5xiiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MN8_A_HFGA603_1 (UNCHARACTERIZEDPROTEIN) |
5xii | PROLYL-TRNASYNTHETASE (PRORS) (Toxoplasmagondii) | 4 / 4 | THR A 439GLU A 441ARG A 470HIS A 560 | 86X A1004 (-3.6A)86X A1004 (-3.0A)ANP A1001 ( 2.9A)86X A1004 (-3.7A) | 0.40A | 6mn8A-5xiiA:45.0 | 6mn8A-5xiiA:undetectable |